MedPath

EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL

EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL

Commercialized
Register Number

1211531001

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Apr 21, 2021

Dosage Form

POLVO PARA SOLUCIÓN ORAL

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1211531001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RISDIPLAMActive
Quantity: 0,75 mg
Name: RISDIPLAM

ATC CLASSIFICATION (3)

M09A
M09AX
M09AX10

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.